ROIVANT SCIENCES LTD
ROIV·G76279101·US·Common Stock·Healthcare - Biotechnology-13D/G
ROIV (ROIVANT SCIENCES LTD) is held by 190 institutional investors as of Q1 2026. Largest holders: FMR LLC ($2.2B), MORGAN STANLEY ($1.4B), BlackRock, Inc. ($1.2B). Net institutional sentiment: Mixed. In Q1 2026, 2 members of Congress and 128 funds bought ROIV.
190
Holders
(17 Elite)
$12.1B
Total Value
64% (201)
Consensus
128 buying - 73 selling
13F: Insider & Congress:
Who's Trading
InsiderVEVenker EricSell $5.1MJun 24, 2026
InsiderVEVenker EricSell $1.5MJun 24, 2026
ActivistRVRamaswamy Vivek3.6%May 6, 2026
InsiderVEVenker EricSell $5.9MApr 20, 2026
InsiderGMGline MatthewSell $8.4MApr 16, 2026
Showing 1-20 of 209
1 / 11
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer